Cargando…
Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
Up to 35% of aggressive pituitary tumors recur and significantly affect mortality and quality of life. Management can be challenging and often requires multimodal treatment. Current treatment options, including surgery, conventional medical therapies such as dopamine agonists, somatostatin receptor...
Autores principales: | Nakano-Tateno, Tae, Lau, Kheng Joe, Wang, Justin, McMahon, Cailin, Kawakami, Yasuhiko, Tateno, Toru, Araki, Takako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033019/ https://www.ncbi.nlm.nih.gov/pubmed/33841328 http://dx.doi.org/10.3389/fendo.2021.624686 |
Ejemplares similares
-
MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019) -
LBODP078 Role Of Ire1a-xbp1 Pathway In Rodent Functional Pituitary Tumor Cells.
por: Nezu, Masahiro, et al.
Publicado: (2022) -
Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019) -
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
por: Bianchi, Antonio, et al.
Publicado: (2023) -
A Rare Case of Recurrent Pituitary Collision Tumors
por: Shakally, Almoutaz, et al.
Publicado: (2020)